FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacy and represents a combination for treating allergic symptoms of skin, mucosa or eye mucosa, containing at least one active substance representing dexpanthenol, and at least one antiallergic active substance of the antihistamine group consisting of azelastin and levocabastin.
EFFECT: invention provides a synergetic effect of the active ingredients of the combination, as well as provides skin and nasal mucosa moistening thereby reducing such side effects as dry nose and nose bleed.
15 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR NASAL PREPARATION | 2015 |
|
RU2605617C1 |
MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING SKIN ITCHING | 2012 |
|
RU2543326C2 |
AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
PHARMACEUTICAL COMPOSITION, CONTAINING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE, FOR NASAL INTRODUCTION | 2011 |
|
RU2563115C2 |
GEL, POSSESSING ANTI- INFLAMMATORY AND ANTIALLERGIC EFFECT | 2008 |
|
RU2370265C1 |
COMBINED PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION | 2018 |
|
RU2736940C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES | 2013 |
|
RU2553600C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF FOAM AEROSOL POSSESSING ANTI-INFLAMMATORY, REGENERATIVE AND ANTIMICROBIAL ACTION, AND METHOD FOR PREPARING IT | 2013 |
|
RU2542448C1 |
THERAPEUTIC AGENT FOR TREATING RHINITIS | 2010 |
|
RU2502519C2 |
Authors
Dates
2013-01-20—Published
2008-06-07—Filed